@article{044c47668af94921971d4928b4ced324,
title = "Liquid biopsy: A tool for the diagnostic and prognostic evaluation of cancers",
abstract = "Liquid biopsy is defined as the process of obtaining material for pathologic examination and analysis from body fluids. Liquid biopsy has been intensively researched for its clinical application in patients with solid malignancies, including melanoma and colon, breast, and lung cancers. This will become a standard and routine tool for the diagnostic and prognostic evaluation of all cancer types. This article provides an overview of liquid biopsy, its uses in cancer management, and its implications for nursing practice.",
keywords = "Genetic biomarkers, Genomic data, Liquid biopsy, Precision medicine",
author = "Joshua Stanciu and Tariman, {Joseph D.}",
note = "Funding Information: The Precision Medicine Initiative is one of the priority areas of research at the National Institutes of Health and its many centers because of funding provided by Congress and the support of President Barack Obama in 2016 (U.S. National Library of Medicine, 2020). In an advocacy role, oncology nurses can provide testimony about the value of establishing liquid biopsy as a standard of care in clinical practice. Nurses also can offer their expertise to the interprofessional care team, based on their knowledge about liquid biopsy options, genomic and immunologic data provided by liquid biopsies, and commercially available molecular targeting (Horowitz et al., 2019). Publisher Copyright: {\textcopyright} 2020 by the Oncology Nursing Society.",
year = "2020",
month = feb,
doi = "10.1188/20.CJON.19-21",
language = "English (US)",
volume = "24",
pages = "19--21",
journal = "Clinical journal of oncology nursing",
issn = "1092-1095",
publisher = "Oncology Nursing Society",
number = "1",
}